Meeting
2012 Genitourinary Cancers Symposium
Tolerability of and biochemical control of permanent pd-103 brachytherapy followed by external beam radiotherapy for localized prostate adenocarcinoma.
Authors
Samuel M. Richter
SUNY Upstate Medical University, Syracuse, NY
Samuel M. Richter , Paul D. Aridgides , Oleg Shapiro , Jesse N. Aronowitz , Jeffrey Bogart
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 245)
DOI
10.1200/jco.2012.30.5_suppl.245
Abstract #
245
Poster Bd #
D23
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Does the choice of hormone therapy affect medium-term outcomes following radical external beam radiotherapy for localized prostate cancer?
First Author: Ciara Lyons
Poster
2015 Genitourinary Cancers Symposium
ASCENDE-RT*: A multicenter, randomized trial of dose-escalated external beam radiation therapy (EBRT-B) versus low-dose-rate brachytherapy (LDR-B) for men with unfavorable-risk localized prostate cancer.
First Author: W. James Morris
Poster
2015 Genitourinary Cancers Symposium
Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
First Author: Phillip John Gray
Poster
2023 ASCO Genitourinary Cancers Symposium
Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).
First Author: Atsunori Yorozu